JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M006648200 on November 28, 2000

J. Biol. Chem., Vol. 276, Issue 10, 7391-7396, March 9, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/10/7391    most recent
M006648200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blandl, T.
Right arrow Articles by Castellino, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blandl, T.
Right arrow Articles by Castellino, F. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Sequence Requirements for the N-Methyl-D-aspartate Receptor Antagonist Activity of Conantokin-R*

Tamas Blandl, Jaroslav Zajicek, Mary Prorok, and Francis J. CastellinoDagger

From the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556

Conantokin-R (con-R), a gamma -carboxyglutamate-containing 27-residue peptide, is a natural peptide inhibitor of the N-methyl-D-aspartate (NMDA) subtype glutamate receptor. Synthetic analogs of con-R were generated to evaluate the importance of the individual structural elements of this peptide in its NMDA receptor antagonist activity, measured by inhibition of the spermine-enhanced binding of the NMDA receptor-specific channel blocker, [3H]MK-801, to rat brain membranes. Progressive C-terminal truncations of the 27-residue peptide revealed stages of severe activity loss. These occurred at con-R[1-11] and con-R[1-7], corresponding to the deletions of Leu12-Pro27 and Met8-Pro27 respectively. A second set of analogs featured single Ala substitutions in the fully active con-R[1-17] fragment. The replacement of Met8 and Leu12 by Ala resulted in approximate 20- and 55-fold decreases of inhibitor potency, respectively. In addition to these two residues, the only other positions where a single Ala substitution led to substantial losses (from 11-fold to >1000-fold) of activity were those of the first five N-terminal amino acids. Based on the above findings, the binding epitope of con-R was localized to the N-terminal turn of the helix and other residues on one face along two subsequent turns. This contribution pattern of the side chains in activity closely resembles the results obtained with another member of this peptide family, conantokin-T. The secondary structure and metal ion binding properties of the con-R variants were also evaluated using circular dichroism spectroscopy. Divalent cation-dependent increases of alpha -helix content were observed in most analogs. However, analogs with replacement of Gla11 and Gla15, as well as truncation fragments shorter than 15 residues, lost the ability to be stabilized by metal ions. These results confirmed the location of the primary divalent cation binding locus at Gla11 and Gla15. Additional interactions were indicated by the reduced alpha -helix stability in the Ala analogs of Gla4, Lys7, and Arg14.


* This work was supported by Grant HL-19982 from the National Institutes of Health (to F. J. C.), a Kleiderer-Pezold family endowed professorship (to F. J. C.), an American Heart Association Scientist Development Grant (to M. P.), and a predoctoral fellowship from the American Heart Association, Indiana Affiliate (to T. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556. Tel.: 219-631-6456; Fax: 219-631-8017; E-mail: castellino.1@nd.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. W. Teichert, E. C. Jimenez, V. Twede, M. Watkins, M. Hollmann, G. Bulaj, and B. M. Olivera
Novel Conantokins from Conus parius Venom Are Specific Antagonists of N-Methyl-D-aspartate Receptors
J. Biol. Chem., December 21, 2007; 282(51): 36905 - 36913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Klein, M. Prorok, Z. Galdzicki, and F. J. Castellino
The Amino Acid Residue at Sequence Position 5 in the Conantokin Peptides Partially Governs Subunit-selective Antagonism of Recombinant N-Methyl-D-aspartate Receptors
J. Biol. Chem., July 13, 2001; 276(29): 26860 - 26867.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.